Cardiology: a solid commitment
Solvay Pharmaceuticals is determined to attain a prominent presence in the field that deals with the world’s number one cause of death, the cardiovascular area. Important results have already been achieved in this area. Omacor® for instance, which is used in combination with other products for the secondary prevention of post-Myocardial Infarction has proven to save lives of people who suffered from a heart-attack. Physiotens® and Teveten® are our solutions for treating high blood pressure.